HUM vs TLRY · P/E 39, rev $117.76B vs rev $821.3M
Humana Inc (HUM) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported TLRY revenue for 2025-05-31 was $821.3M. Net income was -$2.18B. Revenue was up 4.1% from 2024-05-31 to 2025-05-31. TLRY currently screens at market cap $573.9M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the HUM and TLRY stock pages for the full models.
Not investment advice.